Cue Biopharma, Inc. Stock Prediction
AI-powered sentiment analysis and prediction trends for CUE, updated each market day.
CUE AI Sentiment
AI predicts Cue Biopharma, Inc. stock is likely to decrease over the next 10 market days.
Prediction date: Sept. 22, 2026
Exact scores are in the SharePreds app
The precise prediction score for this stock, with buy and sell targets and a stop loss, updated every market day.
About Cue Biopharma, Inc.
Cue Biopharma Inc is a clinical-stage therapeutics company focused on advancing a robust portfolio of potentially transformative therapies aimed at enabling functional cures across immunological disorders. Its product pipeline includes CUE-221, an anti-IgE antibody candidate being developed for allergic diseases. The company has also developed the Immuno-STAT platform for targeting disease-related T cells and is developing CUE-401, an IL-2 and TGF-B therapeutic candidate for autoimmune diseases.
Sector
Exchange
Market Cap
$274,885,425
Cap Tier
Employees
29
Headquarters
BOSTON, MA
Listed Since
Jan. 2, 2018
Website
CUE Sentiment Trend: Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
CUE Volatility
Cue Biopharma, Inc. has shown high price volatility over the last 5 trading days. High volatility means larger price swings: this can present both opportunity and risk for traders.
